Jose Carlos Gutierrez Ramos Danaher Corp (DHR) insider trading activity

Jose Carlos Gutierrez Ramos is SVP, Chief Science Officer of DANAHER CORP . Currently has a direct ownership of 12,156 shares of DHR, which is worth approximately $2.59 Million. The most recent transaction as insider was on Mar 01, 2025, when has been sold 216 shares (Common Stock) at a price of $207.76 per share, resulting in proceeds of $44,876. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.2K

6.19% 3M change

6.19% 12M change

Total Value Held $2.59 Million

Jose-Carlos Gutierrez-Ramos Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 01 2025	SELL Payment of exercise price or tax liability	$44,876 $207.76 p/Share	216 Reduced 1.75%	12,156 Common Stock
Feb 24 2025	SELL Payment of exercise price or tax liability	$123,728 $211.14 p/Share	586 Reduced 4.52%	12,372 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	2,932 Added 18.45%	12,958 Common Stock
Feb 26 2024	SELL Payment of exercise price or tax liability	$219,825 $253.84 p/Share	866 Reduced 7.95%	10,026 Common Stock
Feb 21 2024	BUY Grant, award, or other acquisition	-	3,155 Added 22.46%	10,892 Common Stock
Aug 21 2023	SELL Open market or private sale	$147,818 $250.54 p/Share	590 Reduced 7.84%	6,939 Common Stock
May 01 2023	SELL Open market or private sale	$121,095 $242.19 p/Share	500 Reduced 6.23%	7,529 Common Stock
Feb 24 2023	SELL Payment of exercise price or tax liability	$119,826 $249.12 p/Share	481 Reduced 10.7%	4,014 Common Stock
Feb 24 2023	BUY Grant, award, or other acquisition	-	4,015 Added 33.34%	8,029 Common Stock
Feb 24 2022	SELL Payment of exercise price or tax liability	$70,606 $271.56 p/Share	260 Reduced 10.22%	2,285 Common Stock
Feb 24 2022	BUY Grant, award, or other acquisition	-	2,210 Added 32.96%	4,495 Common Stock
Feb 24 2021	BUY Grant, award, or other acquisition	$567,535 $223.0 p/Share	2,545 Added 50.0%	2,545 Common Stock

Also insider at

BCYC

BICYCLE THERAPEUTICS plc Healthcare

EVLO

Evelo Biosciences, Inc. Healthcare

Director